<DOC>
	<DOCNO>NCT02546492</DOCNO>
	<brief_summary>This open label safety feasibility trial use Acthar® addition investigator center-specific standard therapy , could include increase maintenance immunosuppression , high dose IVIG ( 2 g/Kg ) , and/or Rituximab , patient CAMR .</brief_summary>
	<brief_title>Treatment Chronic Antibody-mediated Rejection Kidney Transplant With Acthar</brief_title>
	<detailed_description>Subjects receive Acthar® 40 unit twice week subcutaneously 2 week . If drug well tolerate dose increase 80 unit twice week another 22 week . The patient maintain center-specific standard maintenance regimen , typically consist Tacrolimus , mycephenolate mofetil/Sodium , prednisone . After screen inclusion/exclusion criterion , patient consent enrolled study . The initial visit subsequent study-related visit 4 , 8 , 12 , 24 , 36 52 week include routine evaluation physical examination laboratory study include CBC , electrolyte panel , eGFR , albumin , liver enzymes , CNI/sirulimus drug level , accord center 's standard care . DSA test week 24 , 52 patient undergo biopsy week 52 , part investigator standard care . The biopsy evaluate light electron microscopy use standard histological Banff criterion , stain CD68 .</detailed_description>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>Age &gt; 18 year Morphologic diagnosis CAMR , light &amp; /or electron microscopy time transplantation Current previously document donorspecific antibody ( DSA ) and/or focal diffuse peritubular capillary C4d stain immunohistochemistry eGFR &gt; 25 ml/min Diagnosis malignancy within year prior enrollment ( except cure cutaneous basal cell squamous cell carcinoma ) . Lack evidence antibody involvement Pregnancy , lactation , refusal use birth control woman child bear potential Active infection , history HIV History liver thoracic transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>